Watch MAZE. Know when insiders buy.
One email the day a filing lands. Free.
MAZE
Maze Therapeutics, Inc.
32.67
+0.22 +0.68%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
39
FLAG · insiders 25, shorts 53
Insiders, 90 days
−$4.5M
net selling · 0 buys, 23 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.8BP/E —DIV YIELD —FCF YIELD -5.89%REV TTM —NET INCOME −$133.6MNET CASH $163.7M52W 22.39 – 51.83NEXT EARNINGS Nov 5 EST.SEC XBRL · TTM TO Invalid Date
Who holds it
None of the 15 tracked funds disclose MAZE in their latest 13F. The funds we follow.
13F filings cover US-listed holdings and arrive up to 45 days after quarter end, so positions may have changed since.
Stakes of 5% or more
No 13D or 13G filing on MAZE in the last two years from the filings we read (13G only for companies we track; the sweep began Sep 2026).
A 13D means the holder crossed 5% with intent beyond passive ownership and had to state a purpose; a 13G is the passive version. Every new 13D on tracked companies.